Catalyst overview
Research summary
This catalyst tracks a Phase 2b data readout for IMVT-1402 in Rheumatoid arthritis. The expected timing is based on the latest available company guidance and may change.
05/20/26:- D2T RA Week 16 responses reported; further updates expected in H2 2026. 08/06/26:- D2T RA program updates remain expected in H2 2026.
Verification
Confirm timing and program details against the company announcement or filing.